Literature DB >> 2536219

Loss of heterozygosity in a gene coding for a thyroid hormone receptor in lung cancers.

F Leduc1, H Brauch, C Hajj, A Dobrovic, F Kaye, A Gazdar, J W Harbour, O S Pettengill, G D Sorenson, A van den Berg.   

Abstract

The ERBA beta gene codes for a DNA-binding thyroid hormone receptor (THR) and maps to chromosome 3p21-p25, overlapping a 3p deletion characterizing small-cell lung carcinoma (SCLC). A DNA clone detecting an RFLP at the ERBA beta locus has been used to probe a large number of lung tumors. Virtually all SCLC had lost heterozygosity, showing that the 3p deletion in SCLC includes this gene. A substantial but smaller proportion of non-small-cell carcinomas had lost heterozygosity at ERBA beta. Among all non-small-cell tumors some had lost heterozygosity at the proximal locus DNF15S2 (band 3p21) but not at ERBA beta, whereas none were found where the reverse was true. Therefore, the locus which plays a role in non-small-cell tumorigenesis probably lies closer to DNF15S2 than to ERBA beta and is almost certainly not the latter.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2536219      PMCID: PMC1715394     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  13 in total

1.  Sequences homologous to the human D1S1 locus present on human chromosome 3.

Authors:  B Carritt; H M Welch; N J Parry-Jones
Journal:  Am J Hum Genet       Date:  1986-04       Impact factor: 11.025

2.  A frequent HindIII RFLP on chromosome 3p21-25 detected by a genomic erbA beta sequence.

Authors:  J L Gareau; B Houle; F Leduc; W E Bradley; A Dobrovic
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

3.  The c-erb-A gene encodes a thyroid hormone receptor.

Authors:  C Weinberger; C C Thompson; E S Ong; R Lebo; D J Gruol; R M Evans
Journal:  Nature       Date:  1986 Dec 18-31       Impact factor: 49.962

Review 4.  Cellular mechanism of action of thyroid hormones.

Authors:  I Di Liegro; G Savettieri; A Cestelli
Journal:  Differentiation       Date:  1987       Impact factor: 3.880

5.  Karyotypic characterization of established cell lines and short-term cultures of human lung cancers.

Authors:  L Zech; J Bergh; K Nilsson
Journal:  Cancer Genet Cytogenet       Date:  1985-02-15

6.  Deletion 3p in two lung adenocarcinomas metastatic to the brain.

Authors:  J A Rey; M J Bello; J M de Campos; M E Kusak; S Moreno; J Benítez
Journal:  Cancer Genet Cytogenet       Date:  1987-04

7.  Specific chromosome defect associated with human small-cell lung cancer; deletion 3p(14-23).

Authors:  J Whang-Peng; C S Kao-Shan; E C Lee; P A Bunn; D N Carney; A F Gazdar; J D Minna
Journal:  Science       Date:  1982-01-08       Impact factor: 47.728

8.  Loss of heterozygosity on chromosomes 3, 13, and 17 in small-cell carcinoma and on chromosome 3 in adenocarcinoma of the lung.

Authors:  J Yokota; M Wada; Y Shimosato; M Terada; T Sugimura
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

9.  erbA-related sequence coding for DNA-binding hormone receptor localized to chromosome 3p21-3p25 and deleted in small cell lung carcinoma.

Authors:  A Dobrovic; B Houle; A Belouchi; W E Bradley
Journal:  Cancer Res       Date:  1988-02-01       Impact factor: 12.701

10.  Dicentric isochromosome for the long arm of chromosome #17, dic i(17q), in a patient with chronic myelogenous leukemia (CML).

Authors:  J Whang-Peng; E Lee; T Knutsen; D Solanki
Journal:  Cancer Genet Cytogenet       Date:  1981-04
View more
  14 in total

Review 1.  Thyroid hormone receptors and cancer.

Authors:  Won Gu Kim; Sheue-yann Cheng
Journal:  Biochim Biophys Acta       Date:  2012-04-06

2.  Expression of the ErbA-beta class of thyroid hormone receptors is selectively lost in human colon carcinoma.

Authors:  S Markowitz; M Haut; T Stellato; C Gerbic; K Molkentin
Journal:  J Clin Invest       Date:  1989-11       Impact factor: 14.808

3.  Inhibition of tumorigenesis by the thyroid hormone receptor β in xenograft models.

Authors:  Won Gu Kim; Li Zhao; Dong Wook Kim; Mark C Willingham; Sheue-yann Cheng
Journal:  Thyroid       Date:  2013-09-04       Impact factor: 6.568

4.  Loss of tyrosine phosphorylation at Y406 abrogates the tumor suppressor functions of the thyroid hormone receptor β.

Authors:  Jeong Won Park; Li Zhao; Mark C Willingham; Sheue-Yann Cheng
Journal:  Mol Carcinog       Date:  2016-06-14       Impact factor: 4.784

5.  SKP2 Activation by Thyroid Hormone Receptor β2 Bypasses Rb-Dependent Proliferation in Rb-Deficient Cells.

Authors:  Xiaoliang L Xu; Zhengke Li; Aihong Liu; Xianqun Fan; Dan-Ning Hu; Dong-Lai Qi; David W Chitty; Renbing Jia; Jianping Qui; Justin Q Wang; Jake Sharaf; Jun Zou; Rebecca Weiss; Hongyan Huang; Walter J Joseph; Lily Ng; Richard Rosen; Binghui Shen; Mark W Reid; Douglas Forrest; David H Abramson; Samuel Singer; David Cobrinik; Suresh C Jhanwar
Journal:  Cancer Res       Date:  2017-09-28       Impact factor: 12.701

6.  Analysis of Thyroid Tumorigenesis in Xenograft Mouse Model.

Authors:  Xuguang Zhu; Sheue-Yann Cheng
Journal:  Methods Mol Biol       Date:  2018

7.  Inhibition of estrogen-dependent tumorigenesis by the thyroid hormone receptor β in xenograft models.

Authors:  Jeong Won Park; Li Zhao; Sheue-Yann Cheng
Journal:  Am J Cancer Res       Date:  2013-06-20       Impact factor: 6.166

8.  Thyroid hormone receptor β suppresses SV40-mediated tumorigenesis via novel nongenomic actions.

Authors:  Dong Wook Kim; Li Zhao; John Hanover; Mark Willingham; Sheue-Yann Cheng
Journal:  Am J Cancer Res       Date:  2012-08-23       Impact factor: 6.166

Review 9.  Thyroid hormone actions in liver cancer.

Authors:  Sheng-Ming Wu; Wan-Li Cheng; Crystal D Lin; Kwang-Huei Lin
Journal:  Cell Mol Life Sci       Date:  2012-09-06       Impact factor: 9.261

10.  Thyroid hormone regulates stromelysin expression, protease secretion and the morphogenetic potential of normal polarized mammary epithelial cells.

Authors:  M López-Barahona; I Fialka; J M González-Sancho; M Asunción; M González; T Iglesias; J Bernal; H Beug; A Muñoz
Journal:  EMBO J       Date:  1995-03-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.